Marimed Stock Investor Sentiment

MRMD Stock  USD 0.11  0.01  8.33%   
About 62% of Marimed's investor base is looking to short. The analysis of current outlook of investing in Marimed suggests that many traders are alarmed regarding Marimed's prospects. The current market sentiment, together with Marimed's historical and current headlines, can help investors time the market. In addition, many technical investors use Marimed stock news signals to limit their universe of possible portfolio assets.
Marimed otc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Marimed daily returns and investor perception about the current price of Marimed as well as its diversification or hedging effects on your existing portfolios.
  
over two weeks ago at news.google.com         
MRMD Revenue per Share 0.42 - GuruFocus.com
Google News at Macroaxis
over a month ago at news.google.com         
MariMed Stock Price Up 0.4 percent - Heres Why - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Is MariMed A Safe Haven In The Wake Of Floridas Cannabis Legalization Defeat - Benzinga
Google News at Macroaxis
over two months ago at news.google.com         
MariMed Launches Natures Heritage Solventless Live Rosin in Massachusetts - Marketscreener.com
Google News at Macroaxis
over two months ago at news.google.com         
MariMed Reports Third Quarter 2024 Earnings - Marketscreener.com
Google News at Macroaxis
over two months ago at news.google.com         
MRMD Shares Outstanding 381.0 Mil - GuruFocus.com
Google News at Macroaxis
over two months ago at news.google.com         
Brokers Issue Forecasts for MariMed FY2026 Earnings - MarketBeat
Google News at Macroaxis
over two months ago at news.google.com         
MariMed Inc Q3 2024 Earnings Call Highlights Navigating Growth Amid Industry Challenges - Yahoo Fina...
Google News at Macroaxis
over two months ago at news.google.com         
MariMed Inc. Reports Third Quarter 2024 Earnings - TipRanks
Google News at Macroaxis
over two months ago at news.google.com         
MariMed Reports Third Quarter 2024 Earnings - GlobeNewswire
Google News at Macroaxis
over two months ago at news.google.com         
Exploring MariMeds Earnings Expectations - Benzinga
Google News at Macroaxis
over three months ago at news.google.com         
MariMed Inc. Commences Cultivation Operations in Mt. Vernon, Illinois Grow Facility - Marketscreener...
Google News at Macroaxis
over three months ago at news.google.com         
MariMed Inc Q2 2024 Earnings Call Highlights Strong Revenue Growth Amid Margin Pressures - Yahoo Fin...
Google News at Macroaxis
over three months ago at news.google.com         
MariMed Inc. Short Interest Down 49.7 percent in August - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
MariMed Inc. Announces Opening of Second Maryland Dispensary - Marketscreener.com
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Marimed that are available to investors today. That information is available publicly through Marimed media outlets and privately through word of mouth or via Marimed internal channels. However, regardless of the origin, that massive amount of Marimed data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Marimed news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Marimed relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Marimed's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Marimed alpha.

Marimed Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Marimed OTC Stock analysis

When running Marimed's price analysis, check to measure Marimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marimed is operating at the current time. Most of Marimed's value examination focuses on studying past and present price action to predict the probability of Marimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marimed's price. Additionally, you may evaluate how the addition of Marimed to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
CEOs Directory
Screen CEOs from public companies around the world
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges